Rheumatology

Large cohort study finds increased cognitive impairment risk in rheumatoid arthritis, supporting routine cognitive screening in clinical care.

Discover how gut microbiota alterations may drive lupus progression, influence immune responses, and shape treatment outcomes in autoimmune disease.

Behavioural incentives increase daily steps in knee osteoarthritis, but neither incentives nor corticosteroid injections improve symptoms in clinical trial findings.

Low-dose aspirin reduces cardiovascular risk in giant cell arteritis but increases bleeding risk, highlighting a complex clinical trade-off.

Research presented at WCO suggests routine X-rays could rival DXA for osteoporosis risk assessment.

Research presented at WCO suggests men are referred too late for osteoporosis screening, with significantly lower survival after first DXA scans.

Research presented at WCO suggests hyaluronic acid injections provide modest but consistent pain relief in knee osteoarthritis, with strong safety profiles.

Research presented at WCO reveals an AI system using chest X-rays can accurately detect low bone mineral density, enabling scalable osteoporosis screening.

Study highlights fatigue as a key, measurable component of disease burden and treatment response.

A study finds metabolomic signatures linked to healthy diets may reduce knee osteoarthritis risk, with BMI mediating much of the association.

GLP-1 receptor agonists may reduce cardiovascular risk in autoimmune rheumatic diseases, offering new hope for patients and clinicians.

Trial shows clinical and molecular biomarkers can predict flare risk in rheumatoid arthritis during biologic tapering, supporting personalised treatment strategies.

An MRI-based cohort study shows HLA-B27–positive axial spondyloarthritis is linked to higher inflammation and distinct clinical features, with similar treatment use across groups.

A cross-sectional study finds nearly 80% of women with Sjögren’s syndrome experience sexual dysfunction, underscoring the need for routine assessment and support.

Trial finds diacerein does not improve knee pain in osteoarthritis patients with inflammation, questioning its clinical use.

A UK retrospective analysis finds that baseline lung comorbidities, measured using a rheumatic disease–specific index, are linked to interstitial lung disease risk in rheumatoid arthritis.

A multicentre trial will assess whether a nurse led self management intervention improves skills and quality of life in adults with newly diagnosed inflammatory arthritis.

A phase 2 trial found vunakizumab improved ACR20 response rates in active psoriatic arthritis, with sustained benefits and a favourable safety profile.

Data from the LIHOA cohort show that ultrasound-detected synovitis and synovial thickening in hand osteoarthritis are associated with worse hand function but not pain intensity.

Cast immobilisation proved non-inferior to surgery for the treatment of unimalleolar Weber B ankle fractures with a congruent mortise on initial radiography but deemed unstable by external rotation stress testing.

A case series published in BMC Rheumatology describes new-onset inflammatory arthritis following bariatric surgery, with MRI-confirmed axial and peripheral disease requiring advanced treatment.

Real-world data from TriNetX show patients with rheumatoid arthritis have a significantly increased risk of thyroid cancer, highlighting the need for awareness and surveillance.

A randomized controlled trial shows high-intensity interval and strength exercise improves multidimensional fatigue and quality of life in people with rheumatoid arthritis, with benefits lasting 12 months.

A first clinical study suggests allogeneic CD19-targeted CAR-T cell therapy can safely induce durable remission in patients with severe, treatment-refractory systemic lupus erythematosus.

UK Biobank data show people with rheumatoid arthritis have higher risks of heart disease, heart failure, and arrhythmias, with genetic analyses supporting causal links.

A first-in-human pilot trial suggests umbilical cord–derived mesenchymal stem cell eye drops may safely improve symptoms and inflammation in refractory dry eye, including Sjögren’s syndrome.

Randomised trial shows chiropractic care alters stress, immune, and neuroplasticity biomarkers in adults with spinal pain.

New data show hip osteoarthritis does not raise the risk of immune checkpoint inhibitor–induced inflammatory arthritis, while ICI-related arthritis is linked to improved survival.

Evidence from a clinical trial and long-term cohort studies suggests metformin, widely used in diabetes, may reduce knee osteoarthritis pain and lower future osteoarthritis risk.

A national cohort study shows rheumatoid arthritis remission rates in England and Wales have plateaued since 2018, with wide regional variation and delays before specialist referral limiting progress

A target trial emulation study finds no relapse reduction with cyclophosphamide added to glucocorticoids in eosinophilic granulomatosis with polyangiitis without poor-prognosis factors.

A qualitative study reveals how trust, communication, and clear responsibility between doctors influence vaccination uptake in patients with inflammatory rheumatic and musculoskeletal diseases.

New data identify age, anti-β2GP1 antibodies, and low C3 as key risk factors for cerebral small vessel disease in systemic lupus erythematosus, highlighting the need for targeted screening and risk stratification.

A university-based study finds a high prevalence of fibromyalgia symptoms, strongly linked to anxiety, stress, and lifestyle factors among students and staff.

New research identifies age, anti-β2GP1 antibodies, and low complement C3 as key risk factors for cerebral small vessel disease in systemic lupus erythematosus.

RA patients positive for anti-EBV EA-DR IgG antibodies show higher ACPA levels and increased disease activity, suggesting a link between Epstein–Barr virus immune responses and rheumatoid arthritis.

ASAS-PerSpA study finds Japanese patients with axial psoriatic arthritis have lower disease activity and better function than other regions, with notable differences in treatment patterns.

A scoping review shows machine learning models may help predict response to biologic and targeted synthetic DMARDs in rheumatoid arthritis, though validation gaps remain.

A new study shows that grip strength cannot be used as a proxy for core muscle endurance in axial spondyloarthritis, highlighting the need for targeted core assessments.

A six-year cohort study shows low muscle strength, not sarcopenia, is linked to increased falls risk in patients with rheumatoid arthritis, highlighting the importance of functional assessments.

Critically ill patients with systemic lupus erythematosus show reduced ICU survival, driven largely by renal dysfunction, with glucocorticoids potentially mitigating mortality risk.

Real-world data show switching to IL-17 inhibitors after TNF inhibitor failure improves treatment retention compared with TNF cycling in psoriatic arthritis.

A new review highlights kefir-derived peptides, probiotics and kefiran as promising natural strategies for bone health and osteoporosis prevention.

BSR has published an updated guideline on the safe use of csDMARDs, introducing new evidence, paediatric guidance, and risk-adaptive monitoring across the full life course.

Cardiac involvement was found in 35% of patients with EGPA, with pericarditis, myocarditis, and coronary vasospasms driving worse disease activity and prognosis.

New study finds early use of secukinumab in psoriatic arthritis offers no significant advantage over standard step-up treatment after one year.

Study finds body mass index does not affect incidence or progression of distal interphalangeal joint osteoarthritis in rheumatoid arthritis patients.

A new study shows joint hypermobility impairs proprioception but does not reduce strength or functional stability, highlighting the need for targeted neuromuscular training.

New trial shows high-intensity exercise can ease pain and fatigue in systemic sclerosis, improving quality of life and physical function after just 12 weeks.

A new study reveals how Epstein–Barr virus reprogrammes B cells into autoimmune drivers, uncovering a direct mechanism linking EBV infection to lupus development.

A new systematic review shows CAR T-cell therapy delivers high remission rates, reduced disease activity, and low toxicity in refractory lupus, signalling major treatment potential.

New MRI research shows hidden brain structure and white matter changes in lupus patients without neuropsychiatric symptoms, linked to disease duration and organ damage.

A large French cohort study finds that pregnant women with systemic sclerosis face increased risks of preeclampsia, preterm birth, and postpartum disease progression, underscoring the importance of close multidisciplinary care.

Targeted proteomics uncovers protein changes linked to lymphoma risk in Sjögren’s disease, offering potential biomarkers and therapeutic targets.

A new study finds that lower knee extensor power increases the risk of worsening pain in adults with or at risk for osteoarthritis.

Chinese scientists created an adhesive that heals shattered bones, outperforming traditional fixatives over twofold in animals.

A dual-energy CT study shows monosodium urate crystals clear at similar rates in joints and tendons during gout treatment.

Machine learning models accurately predict which psoriatic and axial spondyloarthritis patients will respond to treatment, paving the way for personalised therapy decisions.

An international study identifies distinct gut microbiota linked to interstitial lung disease in systemic sclerosis, revealing potential new treatment targets.

A study in Qatar finds pregnancy outcomes vary by arthritis subtype, with spondyloarthritis showing the best results and rheumatoid arthritis linked to higher complications.

GLP-1RA use lowered cardiovascular, kidney, and mortality risks in patients with lupus and diabetes

These findings strengthen evidence supporting plant-based dietary strategies for gout prevention, highlighting lignans and specific whole grains as protective components.

A Japanese multicentre study has revealed that clinical inertia—the failure to escalate treatment in patients with systemic lupus erythematosus despite active disease—leads to greater organ damage and reduced quality of life.

A new study demonstrates that a modified lung ultrasound (LUS) scoring system can accurately assess severity and prognosis in systemic autoimmune rheumatic disease-associated interstitial lung disease (SARD-ILD).

A study of 226 patients shows virtual rheumatology care is safe and effective, with very low rates of failed visits and no increase in disease-related hospitalizations.

A study of 261 patients with inflammatory joint diseases found that education, employment, and place of residence significantly influence quality of life, while disease type had little effect.

A Japanese study shows avacopan helps induce remission in MPA and GPA while reducing steroid doses and adverse events, even when serum C5a levels remain unchanged.

A prospective study highlights that Takayasu arteritis patients with high ischemic deficits on CT perfusion scans face a sharply elevated risk of strokes and other ischemic events.

A retrospective study has found that male sex and rapidly progressive interstitial lung disease are strong predictors of poor survival in patients with anti-MDA5 dermatomyositis.

A nationwide study of more than 66,000 rheumatoid arthritis patients undergoing joint replacement found that blood transfusions are declining but remain linked to higher complication risks, especially in older adults and those with comorbidities.

A systematic review shows high-intensity interval training (HIIT) is safe for patients with inflammatory arthritis.

A new study reveals that rheumatic patients on JAK inhibitors have weaker T cell responses to SARS-CoV-2 vaccination compared to those on TNF inhibitors.

A randomised double-blind trial in Kosovo found that 4,000 IU of vitamin D daily significantly reduced pain and disease activity in rheumatoid arthritis patients after six months of treatment.

A new study reveals that over a third of Indian rheumatoid arthritis patients experience methotrexate intolerance, with many reporting symptoms like nausea and abdominal discomfort.

In a long-term real-world study, researchers found that flare-based rituximab retreatment for rheumatoid arthritis maintained high drug retention but led to cycles of fluctuating disease activity and wellbeing.

People with idiopathic inflammatory myopathies (IIM) face unique physical and emotional challenges when it comes to exercise.

A UK population-based study found that people with rheumatoid arthritis have a significantly increased risk of venous thromboembolism, including younger patients and those with a normal BMI. The findings highlight the need to assess blood clot risk in all RA patients, regardless of traditional VTE risk factors.

A new study of RA patients in Jordan reveals that disease knowledge is higher among younger, more educated individuals, though income and disease activity have a greater influence on quality of life.

Biologic therapy is commonly continued during pregnancy among women with autoimmune diseases, but usage varies greatly by condition, new research shows.

A randomised trial finds that home-based brain stimulation plus exercise and education reduces pain-related disability in fibromyalgia patients, even among placebo responders.

A nationwide Spanish study finds that nearly half of systemic sclerosis patients experience ARFID symptoms, often driven by GI discomfort and fear around eating.

Japanese researchers have developed an AI system that estimates lumbar and femoral bone mineral density from routine X-rays, offering a new tool for early osteoporosis detection.

A European study of nearly 15,000 patients finds that smoking and high BMI lower the odds of response to TNF inhibitors in axial spondyloarthritis.

Six-year data from Poland’s leading biologic treatment center highlight the real-world success of secukinumab in spondylarthritis, with high response and retention rates.

Discover how a new study suggests stem cell embolisation is safe and effective for knee osteoarthritis treatment.

A new study highlights the pressing need for transparent communication and tailored education for patients managing both rheumatoid arthritis and cancer.

New simulation data suggest that fatigue scores can sometimes be substituted in spondyloarthritis registries, but pain and global scores should remain distinct.

A long-term PsA study shows metabolic syndrome is tied to degenerative spine changes, but not joint damage, offering new insight into managing comorbidities.

An international study shows that many people with lupus are not physically active enough, with low activity levels linked to worse fatigue, stress, and depression.

A new EULAR 2025 study has redefined Behçet’s syndrome subtypes using latent class analysis, revealing five unique phenotypes that may inform personalized treatment strategies.

A new study from EULAR 2025 shows that patients with very early systemic sclerosis have a distinct pro-inflammatory fibroblast profile before any signs of fibrosis appear.

A new analysis from the MONITOR-PsA study, presented at EULAR 2025, demonstrates that a pragmatic treat-to-target (T2T) approach in psoriatic arthritis leads to promising clinical outcomes over 48 weeks.

Presented at EULAR 2025, new 2-year data from the SPACE cohort show that spinal fat lesions on MRI progress in early axial spondyloarthritis, unlike in non-axSpA chronic back pain.

Patients with anti-synthetase syndrome-associated interstitial lung disease show distinct lung imaging and clinical profiles depending on their antibody type, according to a new study.

The UK BIO-FLARE study finds that half of rheumatoid arthritis patients relapse after stopping medication, with flare risk predicted by baseline clinical factors.

A large UK-based study has shown that individuals engaging in regular physical activity have a significantly lower risk of developing systemic lupus erythematosus, with benefits varying by age and sex.

Early initiation and consistent physical therapy may help reduce reliance on intra-articular injections for patients with newly diagnosed knee osteoarthritis, according to new real-world data.

Restoring walking ability after surgery for femoral metastasis is strongly tied to improved one-year survival, with early surgery and chemotherapy aiding recovery.

Anti-inflammatory treatment in RA patients significantly reduced biomarkers like IL-8 and E-selectin, with PET/CT imaging confirming corresponding decreases in arterial inflammation.

A decade-long study has found that people with Sjögren disease are 70% more likely to die than the general population, with infections, cancer, and cardiovascular disease as the top causes.

Researchers from the OsteoLaus cohort have developed a machine learning model to predict fragility fractures in postmenopausal women using bone and body composition data.

A study from the Hertfordshire Cohort has found that older adults with obesity and radiographic knee osteoarthritis experience greater pain and impaired function compared to their non-obese peers.

New data suggest that elderly individuals with type 2 diabetes who initiate GLP-1 receptor agonist therapy may face a slightly higher risk of bone fractures compared to those using other common diabetes

A new study shows that artificial intelligence could be a valuable ally in identifying osteoporotic vertebral compression fractures (VCFs), a common yet underdiagnosed complication of aging.

A new study reveals the C-reactive protein-albumin-lymphocyte (CALLY) index is a strong predictor of long-term survival in rheumatoid arthritis patients.

Transitional and CD21⁻ PD-1⁺ B cells identified at diagnosis were linked to better treatment outcomes in early rheumatoid arthritis, according to a spin-off analysis of the NORD-STAR trial.

A study finds that caffeine intake improves endothelial function in systemic lupus erythematosus by enhancing cell survival and reducing inflammation.

New findings show that eosinophilic granulomatosis with polyangiitis (EGPA) patients in remission may safely reduce mepolizumab dosage, potentially easing long-term treatment burden.

A new study highlights anti-M3R antibodies as markers of a more aggressive clinical phenotype in systemic sclerosis, particularly affecting gastrointestinal health.

Patients with rheumatoid arthritis who stopped TNF inhibitors experienced fewer flares and treatment failures on methotrexate-tacrolimus therapy compared to methotrexate alone, with no major safety concerns.

New long-term study data suggest that patients with rheumatoid arthritis who achieve sustained disease control on baricitinib 4 mg may successfully taper to 2 mg, with the majority maintaining low disease activity or recapturing control if needed.

Asthma may raise the risk of developing osteoarthritis, with socially isolated or lonely individuals facing even greater susceptibility, according to a new large-scale cohort study.

A new study shows that even during the Omicron era, patients with systemic autoimmune rheumatic diseases face significant risks of hospitalisation due to COVID-19, particularly if unvaccinated or on immunosuppressive therapies.

Researchers introduce a new Genetic Progression Score (GPS) that enhances prediction of autoimmune disease progression by integrating biobank and case-control genetic data.

KL-6 and hSP-D levels at baseline, and changes in KL-6 over time, are strongly associated with progression of RA-associated interstitial lung disease, according to a Korean prospective cohort study.

A Danish study finds that symptom interpretation and beliefs about treatment impact how quickly patients with early rheumatoid arthritis seek medical help.

New research from the tREACH cohort reveals that female patients with rheumatoid arthritis experience higher disease activity and functional limitations compared to males, even under treat-to-target care.

Initiating steroid treatment before specialist evaluation may obscure the clinical signs of polymyalgia rheumatica, reducing diagnostic accuracy.

A new study reveals high rates of depression and fibromyalgia in Jordanian women with lupus, calling for an integrated approach to managing both physical and psychological aspects of the disease.

A decade-long study has found that each year of infliximab use is linked to an 11% lower risk of cervical spine deformity in RA patients, potentially extending the known benefits of the drug beyond peripheral joints.

A new study suggests that arthritis, particularly osteoarthritis, may increase the risk of overactive bladder.

Patients with systemic sclerosis (SSc) face a higher risk of death from lung, gynecological cancers, and T/NK lineage lymphomas, according to a new study.

A recent study has found that gastrointestinal symptoms and depression are strongly linked to higher disease activity in spondyloarthritis patients.

A recent study highlights the role of inflammation in osteoporosis, identifying AISI, SIRI, and SII as key inflammatory markers associated with lower bone mineral density (BMD) in older adults.

While patients with rheumatoid arthritis have a lower overall cancer incidence rate, they face higher post-cancer mortality.

ChatGPT4 may be a game-changer for patient education in lupus, with a new study showing its responses match or even exceed those of specialists in key areas like patient satisfaction and empathy.

Obesity significantly diminishes the effectiveness of urate-lowering therapy in male gout patients, according to a new study. Only 38.9% of obese patients achieved target serum urate levels compared to 63.8% of normal-weight patients, highlighting the need for integrated weight management in gout treatment.

A Mediterranean diet combined with exercise significantly improves muscle function, pain, and inflammation in females with rheumatoid arthritis.

A new predictive model accurately assesses arthritis risk using common health indicators, offering potential for early prevention.

Study reveals ANCA positivity in 22.4% of patients with ILD, with implications on survival.

New research suggests that patients with obesity who undergo knee or hip replacements can lower their risk of revision surgery by losing weight after the procedure with anti-obesity medications.

A large-scale analysis of five clinical trials of belimumab has found that normalizing serology enhances the effectiveness of treat-to-target strategies in SLE.

New research suggests that cycling between JAK inhibitors may be more effective than switching to biologic DMARDs in rheumatoid arthritis patients who do not initially respond to JAKis.

New research reveals that nearly 40% of young PsA patients develop degenerative disc disease (DDD), with age, male sex, and diabetes as key risk factors. The study also found that inflammatory back pain does not reliably distinguish between axial PsA and spinal degeneration, complicating diagnosis and treatment.

A study from South Korea reveals that rheumatoid arthritis (RA) significantly increases the risk of kidney cancer, particularly among women. Despite the lack of association with bladder, prostate, and testicular cancers, the findings stress the importance of early detection in RA patients.

A wearable device reduced fatigue and Raynaud symptoms in systemic sclerosis, improving quality of life without adverse effects.

A study revealed that early menopause and fewer reproductive years significantly increase the risk of ACPA-negative inflammatory arthritis.

A new Japanese retrospective study confirms that avacopan can effectively induce and sustain remission in patients with ANCA-associated vasculitis, reducing the need for glucocorticoids.

A new study revealed that adding urine alkalization therapy to febuxostat treatment in gout patients with low urinary pH leads to fewer flares, improved kidney health, and better lipid profiles.

A new machine learning model, CAPI-Detect, has demonstrated over 90% accuracy in diagnosing systemic sclerosis (SSc) using nailfold videocapillaroscopy (NVC).

A new study suggests that menopausal hormone therapy (MHT) may increase the risk of systemic lupus erythematosus and systemic sclerosis.

Secukinumab shows high drug survival and sustained effectiveness in psoriatic arthritis patients, with better outcomes in mixed peripheral and axial involvement.

A study of over 1,700 psoriatic arthritis patients across nine European countries reveals that tumor necrosis factor inhibitors (TNFi) work differently depending on the affected joint.

A new study has found a causal link between rheumatoid arthritis and an increased risk of prostate cancer, highlighting the role of chronic inflammation in cancer development.

A new study has found strong genetic evidence that air pollution can significantly increase the risk of autoimmune diseases, including rheumatoid arthritis and lupus.

A new study shows that biologic treatments significantly reduce inflammation and improve jaw function in children with juvenile idiopathic arthritis (JIA) affecting the temporomandibular joint (TMJ).

A study using the KOBIO registry reveals a 39 per 1,000 person-year infection rate in ankylosing spondylitis (AS) patients receiving biologics. Respiratory tract infections and herpes zoster were the most common, with age, diabetes, and kidney disease among key risk factors.

A groundbreaking analysis of the ESTHER trial reveals that resolution of MRI-detected inflammation in the sacroiliac joints is strongly linked to improved clinical outcomes in patients with axial spondyloarthritis undergoing long-term anti-TNF therapy.

A study from the KHOALA cohort reveals that body composition plays a critical role in the quality of life for patients with knee and hip osteoarthritis.

A study finds Sjögren’s disease patients have 70% higher mortality risk, with infections, cancers, cardiovascular issues, and factors like age, low C4, and heart failure.

A new study develops a model to predict gastrointestinal lesions in eosinophilic granulomatosis, highlighting eosinophils as a critical risk factor.

Elevated CRP and ESR levels in rheumatoid arthritis patients are linked to increased risk of developing interstitial lung disease, study shows.

A new diagnostic model combining salivary biomarkers and serum tests offers a non-invasive, highly accurate method to detect primary Sjögren’s disease.

Fibromyalgia affects nearly 20% of lupus patients, significantly worsening their quality of life and highlighting the need for better diagnosis and treatment.

Cardiovascular events during pregnancy heighten risks for preterm birth and SGA infants, especially in autoimmune and rheumatic disease cases.

Strategic tapering with hydroxychloroquine and low disease activity helps lupus patients safely discontinue steroids, reducing flare risks.

Stem-cell transplantation shows promise for children with severe juvenile arthritis and lung disease, offering life-saving potential for refractory cases.

Patients with lupus are over twice as likely to develop cervical artery dissection, emphasizing the need for proactive cardiovascular care.

Bimekizumab reduces pain, stiffness, and fatigue in axial spondyloarthritis, offering a transformative option for managing this chronic condition.

Elevated skin sodium in rheumatoid arthritis may drive hypertension, shedding light on new mechanisms linking immune activation and blood pressure.

Avacopan therapy for vasculitis carries a risk of liver injury, particularly in elderly and low-weight patients, highlighting the need for regular monitoring.

Late-onset rheumatoid arthritis worsens physical function and raises risks of adverse events, including death and malignancy, compared to younger-onset cases.

Male gender and high C3 levels predict early remission in idiopathic retroperitoneal fibrosis, paving the way for tailored treatment strategies.

AI-driven smartphone photos achieve 99% accuracy in detecting early inflammatory arthritis, offering a promising, cost-effective screening tool.

Patients with primary Sjögren’s syndrome and thyroid diseases face heightened risks of malignancy and osteoporosis, linked to changes in immune cell activity, a new study reveals.

Gabapentinoids, widely prescribed for pain management in inflammatory arthritis (IA), are now linked to a 36% higher risk of fractures.

New research highlights that achieving low disease activity or remission in lupus patients significantly reduces organ damage and flare risks.

Obesity may worsen symptoms and increase glucocorticoid requirements in polymyalgia rheumatica, according to new research. Patients with obesity reported greater pain and fatigue and needed higher steroid doses over time despite similar inflammation levels.

Biologic treatments combined with methotrexate or leflunomide show promise in reducing temporomandibular joint inflammation and improving jaw function in children with juvenile idiopathic arthritis.

A new study from the Agricultural Health Study reveals a concerning link between pesticide exposure and an elevated risk of rheumatoid arthritis among older farmers.

A new study highlights increased cancer risks in rheumatoid arthritis patients using biologics like rituximab, abatacept, and JAK inhibitors compared to TNFis.

New research reveals the unexpectedly high prevalence of cutaneous lupus erythematosus in diverse populations, uncovering critical links to systemic lupus progression.

Discover how a mobile app empowers rheumatoid arthritis patients to self-manage symptoms, providing valuable insights without increasing psychological burden.

Limited fasciectomy proves more effective than collagenase injections for improving hand health in patients with Dupuytren’s contracture, new research shows.

Men with systemic sclerosis are more prone to ILD, while women face higher risks of SAD, a study reveals critical sex-related differences.

Reduced-dose steroids increase relapse and progression risk in ANCA-associated vasculitis, particularly in rituximab-treated patients, study shows.

Hydroxychloroquine reduces relapse risk in lupus patients after steroid withdrawal, offering a safer path to long-term disease stability.

One-third of paediatric Behçet’s disease patients face new complications or relapses in adulthood, highlighting the need for lifelong care.

Upper extremity disability in rheumatoid arthritis fluctuates over time, with pain and hand function playing a critical role, study finds.

RA and PsA patients face higher interstitial lung disease risk, but methotrexate does not increase this risk, study finds.

No significant difference found between hydrocortisone replacement and prednisone tapering for glucocorticoid discontinuation in rheumatoid arthritis patients.

Blood flow restriction therapy shows greater pain and strength improvements in knee osteoarthritis, study finds.

Platelet-to-albumin ratio linked to disease activity in early rheumatoid arthritis, with a notable threshold effect.

Significant pain interference affects many children with juvenile idiopathic arthritis, with fatigue and mobility playing key roles, a new study finds.

New study reveals how social disparities impact diagnostic delays in radiographic axial spondyloarthritis.

Telemedicine reduces rheumatology visits and cuts costs for spondyloarthritis patients, study finds.

Adding blood flow restriction to knee osteoarthritis exercises significantly boosts pain relief, strength, and quality of life, new study shows.

No clear winner in rheumatoid arthritis glucocorticoid tapering, as both prednisone and hydrocortisone approaches show similar success in recent study.

Blood-based immunophenotyping may enable personalized rheumatoid arthritis treatments, improving outcomes by matching therapies to patients’ unique immune profiles.

The management of rheumatoid arthritis (RA) has significantly evolved, moving beyond the mere application of clinical trial results to a more nuanced approach…

New research has shown that women with premature ovarian insufficiency (POI) have more than double the prevalence of severe autoimmune diseases compared to the general female population.

The severity of Raynaud’s disease is not only linked to very low temperatures, but also hot environments that reach 35°C and above, according to recent research.  

New research has demonstrated that frailty, a measure of biological age, predicts severe infections in older adults with incident antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis.

Research has shown that long-term use of antibiotics is associated with a higher risk of rheumatoid arthritis. 

Age and hypertension increase cranial ischaemic complication risk in giant cell arteritis, while anticoagulant therapy may be protective

Frailty, more than age, significantly impacts the risk of severe infections in older adults with ANCA-associated vasculitis, according to a new study

A study from SPIN shows that most individuals with systemic sclerosis are vaccinated against COVID-19, with minimal severe side effects and low rates of disease flare-ups.

A study revealed that the severity of Raynaud’s phenomenon, a common early manifestation of systemic sclerosis, is influenced significantly by ambient temperature.

A study compared the effectiveness of three immunomodulatory therapies combined with corticosteroids in preventing uveitis relapse in patients with severe Behcet’s disease.

A RECENT study has found a link between alcohol consumption and the risk of developing gout.

Researchers have identified two new potential biomarkers, which could be crucial in predicting disease activity in children with non-systemic juvenile idiopathic arthritis.

Refracture risk in adult patients who sustain a hip fracture can be mitigated through a new multidisciplinary approach, including fall prevention and anti-osteoporosis medication use.

New study shows that gradual tapering of glucocorticoid steroids in mSACQ state SLE patients can be done without increasing flare risk.

A study has shown the efficacy and safety of first-line biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis who suffer from chronic kidney disease

A new study found that TNF inhibitors have similar rates of adverse events and treatment response in ankylosing spondylitis regardless of when the disease developed.

A recent study investigated the risk of systemic lupus erythematosus associated with long-term exposure to air pollution.

New research reassures that hydroxychloroquine use during the first trimester does not significantly increase the risk of major congenital malformations in infants

Recent research presented at the 2024 EULAR congress has shed light on the disease’s complex mechanisms of Sjögren’s disease

Results presented at EULAR 2024, show reductions in DAS28 scores among rheumatoid arthritis patients following a plant-based, whole-food diet, exercise, and stress management regime.

Researchers presented novel findings on the potential utility of the blood interferon signature in diagnosing and stratifying paediatric Sjögren’s disease.

A new study showed a significant association between secondhand smoke exposure and the risk of developing rheumatoid arthritis

New research on glucocorticoid dosing in lupus nephritis reveals crucial insights into treatment outcomes.

New data has linked the consumption of fish during pregnancy and the first year of life with juvenile idiopathic arthritis.

EULAR has updated its recommendations for systemic sclerosis, incorporating four new therapies presented at its congress in 2024.

The EULAR 2024 congress stressed the importance of supporting transitions from paediatric to adult care to maintain effective treatment for young patients

A study reveals the significant comorbidities linked to osteoarthritis, highlighting the necessity for enhanced management and patient care strategies.

A study presented at EULAR 2024 aimed to investigate the relationship between large-scale pre-diagnostic proteomics and the risk of incident gout in a nationwide prospective cohort.

Research presented at EULAR 2024 aimed to evaluate the prevalence of anti-Ro/SSA antibodies in the largest available cohort of established systemic sclerosis patients.

A recent study highlights the importance of early diagnosis in psoriatic arthritis patients, showing that shorter delays lead to better clinical outcomes.

Recent study highlights sex differences in disease activity measures and treatment responses among patients with axial spondylarthritis

A new blood test has successfully predicted risk of knee osteoarthritis eight years before signs of the disease appeared on X-rays.

Researches have found a link between rheumatoid arthritis and certain gene mutations found in cancer.

A new study found that, among patients with rheumatoid arthritis who are treated with biologic disease-modifying antirheumatic drugs, dementia risk is decreased.

According to recent findings, a weight-bearing activity could contribute to increased odds of radiographic knee osteoarthritis in people with low levels of lower-limb muscle mass.